Fate Therapeutics
Price & Volume
Stats
See more52W Range | $0.91-$2.88 |
Market Cap | $222.6M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $6.3M |
Revenue Growth (YoY) | -20.3% |
Gross Profit (12 Mos) | -$81.1M |
Diluted EPS | -$1.09 |
News
See moreYahoo Finance • 8 days ago
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 15 days ago
Russell 3000 Shuffle: Ocugen, Nektar slated to join among healthcare stocks; Nano-X to drop off
Yahoo Finance • 30 days ago
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
Yahoo Finance • 3 months ago
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
CFO | Mr. Kamal Adawi M.S., MBA |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |